Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MR2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,633
Award facts
- Contract value 100% obligated
- $23,633.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,633.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units), a generic antiemetic medication commonly used in military and federal healthcare settings. This firm fixed-price, non-set-aside contract was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the Defense Logistics Agency's Medical Supply Chain. The company's IDC vehicle enables efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains. As a major distributor supplying the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen competes on a full and open basis for such awards, demonstrating its capability to meet government procurement requirements for essential medications required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9MR2?
SPE2DR26F9MR2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MR2 worth?
The government has obligated $23,633 on SPE2DR26F9MR2.
Is contract SPE2DR26F9MR2 an order under another contract?
Yes. SPE2DR26F9MR2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MR2 competed?
The extent of competition for SPE2DR26F9MR2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award